![Kenneth Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Hoberman
Chief Operating Officer at
STEMLINE THERAPEUTICS, INC.
Net worth: 19 M $ as of 2026-09-29
Profile
Mr. Kenneth Hoberman is an Independent Director at Nuvectis Pharma, Inc., an Independent Director at TG Therapeutics, Inc. and a Chief Operating Officer at Stemline Therapeutics, Inc. He is on the Board of Directors at Lirum Therapeutics, Inc., Nuvectis Pharma, Inc. and TG Therapeutics, Inc. Mr. Hoberman was previously employed as a Vice President-Corporate & Business Development by Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from Boston University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-10 | 279,653 ( 0.18% ) | 16 M $ | 2026-09-29 | |
| 2026-06-10 | 168,140 ( 0.52% ) | 4 M $ | 2026-09-29 |
Kenneth Hoberman active positions
| Companies | Position | Start |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Chief Operating Officer | 2012-12-31 |
| TG THERAPEUTICS, INC. | Director/Board Member | 2014-12-14 |
| NUVECTIS PHARMA, INC. | Director/Board Member | 2021-06-30 |
| LIRUM THERAPEUTICS, INC. | Director/Board Member | 2021-10-31 |
Former positions of Kenneth Hoberman
| Companies | Position | End |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | 2011-12-31 |
Education of Kenneth Hoberman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
TG Therapeutics, Inc.
 TG Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
 Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that focuses on the treatment of debilitating diseases | Commercial Services |
- Stock Market
- Insiders
- Kenneth Hoberman
